Form 8-K · Current report
Amphenol 8-K, filed Sep 4, 2026
- Filed
- CIK
- 0000820313
- Accession no.
- 0001104659-26-105485
Summary
Amphenol's board approved a third-quarter 2026 dividend of $0.25 per share on its Class A Common Stock, payable October 14, 2026 to shareholders of record as of September 22, 2026, alongside a two-for-one stock split distributed September 2, 2026 to holders of record as of August 17, 2026. With the split now effected, the October 14 dividend is $0.125 per share.
Key points
- Amphenol's board approved a third-quarter 2026 dividend of $0.25 per share on its Class A Common Stock, payable October 14, 2026 to shareholders of record as of September 22, 2026.
- The board also approved a two-for-one stock split in the form of a stock dividend distributed September 2, 2026 to holders of record as of August 17, 2026.
- The two-for-one split has been effected, and the October 14 dividend will now be $0.125 per share.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 8.01Other Events
From the filing
Item 8.01 Other Events. On August 6, 2026, Amphenol Corporation (the “Company”) announced that its Board of Directors approved the third quarter 2026 dividend on its Class A Common Stock (the “Common Stock”) in the amount of $0.25 per share. The dividend will be paid on October 14, 2026 to shareholders of record as of September 22, 2026. On August 6, 2026, the Company also announced the approval of a two-for-one stock split of the Common Stock in the form of a stock dividend to be distributed on September 2, 2026, to holders of record of the Common Stock at the close of business on August 17, 2026. The two-for-one stock split referenced above has now been effected. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.